Ubs Asset Management Americas Inc 89bio, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in 89bio, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 140,998 shares of ETNB stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140,998
Previous 139,374
1.17%
Holding current value
$1.11 Million
Previous $1.12 Million
6.54%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ETNB
# of Institutions
158Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$119 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$112 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$63 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$58.1 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$55.3 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $366M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...